Literature DB >> 21802811

Verification of nerve integrity after surgical intervention using quantitative sensory testing.

Sareh Said-Yekta1, Ralf Smeets, Marcella Esteves-Oliveira, Jamal M Stein, Dieter Riediger, Friedrich Lampert.   

Abstract

PURPOSE: The aim of this study was to apply a standardized Quantitative Sensory Testing (QST) approach in patients to investigate whether oral surgery can lead to sensory changes, even if the patients do not report any sensory disturbances. Furthermore, this study determines the degree and duration of possible neuronal hyperexcitability due to local inflammatory trauma after oral surgery. PATIENTS AND METHODS: Orofacial sensory functions were investigated by psychophysical means in 60 patients (30 male, 30 female) in innervation areas of infraorbital nerves, mental nerves and lingual nerves after different interventions in oral surgery. The patients were tested 1 week, 4 weeks, 7 weeks, and 10 weeks postoperatively. As controls for bilateral sensory changes after unilateral surgery, tests were additionally performed in 20 volunteers who did not have any dental restorations.
RESULTS: No differences were found between the control group and the control side of the patients. Although not 1 of the patients reported paresthesia or other sensory changes postoperatively, QST detected significant differences between the control and the test side in the mental and lingual regions. Test sides were significantly less sensitive for thermal parameters (cold, warm, and heat). No differences were found in the infraorbital region. Patients showed significantly decreased pain pressure thresholds on the operated side. QST monitored recovery over time in all patients.
CONCLUSIONS: The results show that oral surgery can lead to sensory deficits in the mental and lingual region, even if the patients do not notice any sensory disturbances. The applied QST battery is a useful tool to investigate trigeminal nerve function in the early postoperative period. In light of the increasing forensic implication, this tool can serve to objectify clinical findings.
Copyright © 2012 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21802811     DOI: 10.1016/j.joms.2011.03.065

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  6 in total

Review 1.  Quantitative sensory testing of neuropathic pain patients: potential mechanistic and therapeutic implications.

Authors:  Doreen B Pfau; Christian Geber; Frank Birklein; Rolf-Detlef Treede
Journal:  Curr Pain Headache Rep       Date:  2012-06

2.  3.0 Tesla MRI in the early evaluation of inferior alveolar nerve neurological complications after mandibular third molar extraction: a prospective study.

Authors:  M Cassetta; N Pranno; F Barchetti; V Sorrentino; L Lo Mele
Journal:  Dentomaxillofac Radiol       Date:  2014-06-20       Impact factor: 2.419

3.  The mental artery: anatomical study and literature review.

Authors:  Shogo Kikuta; Joe Iwanaga; Jingo Kusukawa; R Shane Tubbs
Journal:  J Anat       Date:  2019-11-06       Impact factor: 2.610

4.  Evaluation of the anesthetic effect of epinephrine-free articaine and mepivacaine through quantitative sensory testing.

Authors:  Sareh Said Yekta-Michael; Jamal M Stein; Ernst Marioth-Wirtz
Journal:  Head Face Med       Date:  2015-02-07       Impact factor: 2.151

5.  Profiling intraoral neuropathic disturbances following lingual nerve injury and in burning mouth syndrome.

Authors:  Amely Hartmann; Robin Seeberger; Malte Bittner; Roman Rolke; Claudia Welte-Jzyk; Monika Daubländer
Journal:  BMC Oral Health       Date:  2017-03-23       Impact factor: 2.757

6.  Quantitative sensory testing in physically active individuals and patients who underwent multidisciplinary pain therapy in the longitudinal course.

Authors:  Ulrike Dapunt; Simone Gantz; Anastasiya Zhuk; Katharina Gather; Haili Wang; Marcus Schiltenwolf
Journal:  J Pain Res       Date:  2018-10-16       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.